EUVIMEDEUVIMED entdecken
Crossref

Prognostic Analysis of a Hypoxia-Associated lncRNA Signature in Glioblastoma and its Pan-Cancer Landscape

Yue Qin, Xiaonan Zhang, Yulei Chen, Wan Zhang, Shasha Du, Chen Ren

Journal of Neurological Surgery Part A: Central European Neurosurgery · 01.07.2024 · 85 (04) · 378-388

DOI: 10.1055/a-2070-3715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part A: Central European Neurosurgery, erschienen am 01.07.2024. Verfasst von Yue Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Glioblastoma, RNA, Long Noncoding, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypoxia is an important clinical feature of glioblastoma (GBM), which regulates a variety of tumor processes and is inseparable from radiotherapy. Accumulating evidence suggests that long noncoding RNAs (lncRNAs) are strongly associated with survival outcomes in GBM patients and modulate hypoxia-induced tumor processes. Therefore, the aim of this study was to establish a hypoxia-associated lncRNAs (HALs) prognostic model to predict survival outcomes in GBM patients.

Methods

LncRNAs in GBM samples were extracted from The Cancer Genome Atlas database. Hypoxia-related genes were downloaded from the Molecular Signature Database. Co-expression analysis of differentially expressed lncRNAs and hypoxia-related genes in GBM samples was performed to determine HALs. Six optimal lncRNAs were selected for building HALs models by univariate Cox regression analysis.

Results

The prediction model has a good predictive effect on the prognosis of GBM patients. Meanwhile, LINC00957 among the six lncRNAs was selected and subjected to pan-cancer landscape analysis.

Conclusion

Taken together, our findings suggest that the HALs assessment model can be used to predict the prognosis of GBM patients. In addition, LINC00957 included in the model may be a useful target to study the mechanism of cancer development and design individualized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaRNA, Long NoncodingBrain NeoplasmsHumansPrognosisGene Expression Regulation, NeoplasticBiomarkers, TumorHypoxiaMaleFemaleMiddle Aged

Substanzen

RNA, Long NoncodingBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiation Oncology, Southern Medical University, Guangzhou, China.
  • Department of Radiation Oncology, Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China.

Förderung

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Qin, Y., Zhang, X., Chen, Y., Zhang, W., Du, S., & Ren, C. (2024). Prognostic Analysis of a Hypoxia-Associated lncRNA Signature in Glioblastoma and its Pan-Cancer Landscape. Journal of Neurological Surgery Part A: Central European Neurosurgery, 85(04), 378-388. https://doi.org/10.1055/a-2070-3715

Vancouver

Qin Y, Zhang X, Chen Y, Zhang W, Du S, Ren C. Prognostic Analysis of a Hypoxia-Associated lncRNA Signature in Glioblastoma and its Pan-Cancer Landscape. Journal of Neurological Surgery Part A: Central European Neurosurgery. 2024;85(04):378-388. doi:10.1055/a-2070-3715

BibTeX
@article{Qin2024,
  author = {Qin, Yue and Zhang, Xiaonan and Chen, Yulei and Zhang, Wan and Du, Shasha and Ren, Chen},
  title = {Prognostic Analysis of a Hypoxia-Associated lncRNA Signature in Glioblastoma and its Pan-Cancer Landscape},
  journal = {Journal of Neurological Surgery Part A: Central European Neurosurgery},
  year = {2024},
  volume = {85},
  number = {04},
  pages = {378--388},
  doi = {10.1055/a-2070-3715}
}
Kostenlos starten →